NRIX.O (NRIX.O) News
Follow NRIX.O (NRIX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Nurix Therapeutics Director Julia P. Gregory Reports Sale of Common Shares Worth $528,528.0154
Nurix Therapeutics director Julia P. Gregory sold 22,583 common shares at $23.4038 on Oct. 14, 2026, a Form 4 filing showed. Gregory exercised director stock options to acquire 22,583 common shares at $1.86 per share on
MNA | Oct 14, 2026, 08:17 PM UTC
L
Nurix swings to quarterly net income of 549.81 million; revenue jumps to 673.06 million
Nurix reported revenue of $673.06 million for the three months ended Aug. 31, 2026, up 8,426% year over year. Net income swung to $549.81 million, or $4.73 per diluted share, from a net loss of $86.42 million. Research a
EARNINGS | Oct 12, 2026, 08:06 PM UTC